Trending
- The pancreatic cancer ‘miracle drug’ is just a baby step
- BCL2 promoter region mutations are an independent marker of BCL2 level in lymphoid malignancies
- What Was Really Behind My “Laziness” and What I Know Now
- Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer
- In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis
- I had to crowdfund my cancer treatment in Australia’s ‘universal’ health-care system
- 59 Racialized Economic Segregation and Insurance Disadvantage as Mediators of Racial Disparities in Breast Cancer Stage at Diagnosis
- 60 Racialized Economic Segregation as a Mediator of Racial Disparities in Triple-Negative Breast Cancer
Friday, June 19